Campo-Betancourth CF, Mondragón-Cardona Á, Moreno-Gutiérrez PA, Jiménez-Canizalez CE, Tobón-Garcia D, Martínez JW

Language: Spanish
References: 10
Page: 56-60
PDF size: 160.97 Kb.

ABSTRACT

Cardiovascular diseases (CVD) are caused by heart and blood vessels diseases and seen as a pandemic that affects the general population. The objective of this study is to describe the characterization of cardiovascular risk factors in patients who received attention at Caimalito, Pereira, Colombia. A cross sectional study in patients with identified cardiovascular risk was developed with the application of clinical history. The population was 180 people, 67 people between 5 and 13 years 30 men (44.7%), 37 women (55.3%), and 113 people over 13 years, 33 men (18.3%) 80 women (44.4%). Patients over 13 years found that 51% were located in a BMI range between 18 and 25, and 26.1% were over 25 and 30. 103 people of the total population reported to have pathological conditions. Conditions related to cardiovascular risk were Hypertension (28), Dyslipidemia (9) and Diabetes Mellitus (2). 41 people were smokers and 15 consume alcoholic beverages. Drug use was identified in 108 consultants, with a higher prevalence of antihypertensive drugs (47) and Lipid lowering (6), in lesser extent Antiplatelet agents (5), Anti-anginal (2) and oral Antidiabetic (2). The implementation of public health programs to control modifiable risk factors is essential to reduce chronic diseases and CVD prevalence.

REFERENCES

1. Sánchez-Contreras M, Moreno-Gómez G, Marín-Grisales M, García-Ortiz L. Factores de riesgo cardiovascular en poblaciones jóvenes. Pereira, Risaralda, Colombia. Rev salud pública 2009;11(1):110-22.

2. Organización Mundial de la Salud. En Español. Enfermedades cardiovasculares. centro de prensa. Nota de prensa [Actualizado enero de 2011]. Disponible en: http://www.who.int/mediacentre/factsheets/fs317/es/index.html

3. Tourlouki E, Matalas A, Panagiotakos D. Dietary habits and cardiovascular disease risk in middle-aged and elderly populations: a review of evidence. Greece. Clinical Interventions in Aging 2009; 4 319–330.

4. Chan Ruth S.M, Woo J. Prevention of overweight and obesity: how effective is the current public health approach. Hong Kong, China. Int J Environ Res Public Health 2010; 7: 765-83.

5. Alayón A, Ariza S, Baena K, Lambis L, Martinez L, Benítez L. Búsqueda activa y evaluación de factores de riesgo cardiovascular en adultos jóvenes, Cartagena de Indias, 2007. Cartagena, Colombia. Biomédica 2010;30:238-44.

6. Ali H, Mary K, Dietz W, Bowman B, Marks J, Koplan J. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999; 282:16-24.

7. Picot J, Jones J, Colquitt T, Gopodarevskaya E, Loveman E, Baxter L et al. The clinical effectiveness and cost – efectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Southampton, UK. Health Technology Assessment 2009;13:41-6.

8. Ginsberg H, MacCallum P. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr 2009;4(2):113–9.

9. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations. Can J Cardiol 2009;25(10):115-23.

10. Berlin I. Smoking–induced metabolic disorders: A review. Can J Cardiol 2009; 25(10):43-7.